首页>
外国专利>
Protecting pancreatic beta-cells during islet isolation; assessing islet viability and candidate diabetes drugs after islet isolation
Protecting pancreatic beta-cells during islet isolation; assessing islet viability and candidate diabetes drugs after islet isolation
展开▼
机译：在胰岛分离过程中保护胰岛β细胞;胰岛分离后评估胰岛生存力和候选糖尿病药物
展开▼
页面导航
摘要
著录项
相似文献
摘要
Standard pancreatic islet isolation results in beta-cell toxicity due to nitric oxide and/or streptozotocin-like molecules that are generated during the isolation process. This toxicity can be limited by the addition of compounds that work through the glucosamine pathway in islets and/or by the addition of nitric oxide inhibitors. Unless prevented, this toxicity results in beta-cells being unable to properly respond to high glucose, glucosamine, N-acetylglucosamine, or streptozotocin by increasing their relative amount of O-glycosylated protein. Likewise, in order to assess islet viability or the effect of diabetes drugs on beta-cell function, islets that have been adequately protected during their isolation can be stimulated with low glucose, high glucose, glucosamine, N-acetylglucosamine, or streptozotocin with or without the drug(s) of interest present. By analyzing the pattern of islet protein O-glycosylation that occurs, one can determine whether the islets are viable and whether or not the candidate drug(s) might be useful in the treatment of diabetes.
展开▼
